New data from the Phase 2 OVATION 2 study highlights potential improvements in survival outcomes with IMUNON's IMNN-001 for ...

Cytokine therapies have the potential to transform cancer treatment by enhancing the body’s immune response to fight cancer ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially ...

Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale.

Promises of Innovation, Speed, and Savings,’ the latest research report by S&P Global Ratings. In a special session, we’ll ...

This novel DNA plasmid vaccine targets antigen-presenting cells and aims to induce a robust immune response. Prof. Lindy ...

The U.S. Food and Drug Administration (FDA) has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing (NGS)-based companion diagnostic, to identify patients eligible for ...

Researchers at Weill Cornell Medicine have made a breakthrough in the fight against hepatocellular carcinoma (HCC), by identifying a biomarker that could predict which patients are more likely to ...

Antibody-Drug Conjugates (ADCs) are at the forefront of cancer treatment, providing targeted therapies with promising results for lung cancer. In this exclusive interview, we spoke with Dr. Maria de ...

The Merlin test (CP-GEP), a molecular diagnostic tool developed by SkylineDx, shows promising results in reducing the need for sentinel lymph node biopsy (SLNB) in early-stage melanoma patients, ...